| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.03.24 | InDex Pharmaceuticals Holding AB: CEO and CFO both to leave InDex Pharmaceuticals | 198 | GlobeNewswire (Europe) | March 26, 2024 - InDex Pharmaceuticals Holding AB (publ) ("InDex Pharmaceuticals") today announced that CEO Jenny Sundqvist and CFO & Deputy CEO Johan Giléus will leave the company per September 26... ► Artikel lesen | |
| 26.03.24 | Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants | 126 | GlobeNewswire (Europe) | Company announcement - No. 19 / 2024 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark, March 26, 2024 - Zealand Pharma A/S ("Zealand")... ► Artikel lesen | |
| 26.03.24 | Royal Helium Ltd.: Royal Helium Enters Into Initial Offtake Agreement For The Sale Of Food And Beverage Grade Co2 | 360 | PR Newswire | SASKATOON, SK, March 26, 2024 /CNW/ - Royal Helium Ltd. (TSXV: RHC) (TSXV: RHC.WT.A) (OTCQB: RHCCF) ("Royal" or the "Company") is pleased to announce that it has entered into its first offtake agreement... ► Artikel lesen | |
| 26.03.24 | Laufende Fusionskontrollverfahren: Egeria Capital Management, Erwerb aller Anteile an und der Kontrolle über die Meyer Menü Beteiligungs-GmbH | 414 | Bundeskartellamt | Datum der Anmeldung:26.03.2024Aktenzeichen:B9-38/24Unternehmen:Egeria Capital Management, Erwerb aller Anteile an und der Kontrolle über die Meyer Menü Beteiligungs-GmbHProduktmärkte:Erbringung sonstiger... ► Artikel lesen | |
| 26.03.24 | Laufende Fusionskontrollverfahren: Boels Topholding B.V., Niederlande/Erwerb von 100 % der Anteile an der Riwal Holding Group B.V., Niederlande | 234 | Bundeskartellamt | Datum der Anmeldung:26.03.2024Aktenzeichen:B1-47/24Unternehmen:Boels Topholding B.V., Niederlande/Erwerb von 100 % der Anteile an der Riwal Holding Group B.V., NiederlandeProduktmärkte:Vermietung von... ► Artikel lesen | |
| 26.03.24 | Laufende Fusionskontrollverfahren: Platin 2382. GmbH und Platin 2433. GmbH /Erwerb sämtlicher Anteile an und Alleinkontrolle über elf Wirtschaftsprüfer-, Steuerberater- und Rechtsanwaltskanzleien ('Schwarz-Gruppe') | 586 | Bundeskartellamt | Datum der Anmeldung:26.03.2024Aktenzeichen:B1-48/24Unternehmen:Platin 2382. GmbH und Platin 2433. GmbH/Erwerb sämtlicher Anteile an und Alleinkontrolle über elf Wirtschaftsprüfer-, Steuerberater- und... ► Artikel lesen | |
| 26.03.24 | Binah Capital Group, Inc. Announces Listing on Nasdaq Stock Market LLC | 231 | PR Newswire | NEW YORK, March 26, 2024 /PRNewswire/ -- Binah Capital, Group, Inc. (the "Company") announced today that it has received approval for the Company's securities to be listed on the Nasdaq Stock Market... ► Artikel lesen | |
| 26.03.24 | Orezone Gold Corporation: Orezone Reports 2023 Year-end and Q4 Results, and Provides 2024 Guidance | 892 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, March 26, 2024 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) ("Orezone" or "Company") reported its operational and financial results for the fourth... ► Artikel lesen | |
| 26.03.24 | Movella Holdings, Inc.: Movella Announces Nasdaq's Planned Suspension of Trading of Securities | 487 | GlobeNewswire (Europe) | HENDERSON, Nev., March 26, 2024 (GLOBE NEWSWIRE) -- Movella Holdings Inc. (NASDAQ: MVLA) ("Movella" or the "Company"), a leading full-stack provider of sensors, software, and analytics that enable... ► Artikel lesen | |
| 26.03.24 | Trisura Group Ltd: Trisura Closes the Acquisition of First Founders | 469 | GlobeNewswire (Europe) | TORONTO, March 26, 2024 (GLOBE NEWSWIRE) -- Trisura Group Ltd. ("Trisura" or "Trisura Group") (TSX: TSU), a leading specialty insurance provider, today announced the closing of the acquisition of... ► Artikel lesen | |
| 26.03.24 | GT Biopharma, Inc.: GT Biopharma Reports Fourth Quarter and Full-Year 2023 Financial Results | 187 | GlobeNewswire (Europe) | Remain in active dialogue with the FDA regarding IND clearance for GTB-3650, a 2nd generation nanobody TriKE® for treatment of CD33+ leukemiaPhase 1 trial with GTB-3650 anticipated to start in 2H... ► Artikel lesen | |
| 26.03.24 | Canacol Energy Ltd. Addresses Concerns Regarding Debt Obligations and Liquidity | 240 | GlobeNewswire (Europe) | CALGARY, Alberta, March 26, 2024 (GLOBE NEWSWIRE) -- Canacol Energy Ltd. ("Canacol" or the "Corporation") (TSX:CNE; OTCQX:CNNEF; BVC:CNEC) comments regarding certain concerns of our debt obligations:... ► Artikel lesen | |
| 26.03.24 | Wilhelmina International, Inc. Announces Fourth Quarter and Full Year 2023 Results | 238 | GlobeNewswire (Europe) | Annual Financial Highlights Annual revenues of $17.2 million for 2023.Annual operating income of $0.7 million in 2023.Annual net cash flows provided by operating activities were $0.7 million in 2023.Annual... ► Artikel lesen | |
| 26.03.24 | Nasdaq, Inc.: Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date March 15, 2024 | 162 | GlobeNewswire (Europe) | NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of March 15, 2024, short interest in 3,114 Nasdaq Global MarketSM securities totaled 11,183,649,858 shares compared with... ► Artikel lesen | |
| 26.03.24 | Lifecore Biomedical, Inc.: Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update | 236 | GlobeNewswire (Europe) | CHASKA, Minn., March 26, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore" or the "Company"), a fully integrated contract development and manufacturing organization ("CDMO")... ► Artikel lesen | |
| 26.03.24 | Zevra Therapeutics Announces Top-Line Data from the Phase 2 Clinical Trial of KP1077 for Idiopathic Hypersomnia | 289 | GlobeNewswire (Europe) | KP1077 demonstrates clinically meaningful benefits for key IH symptoms Top-line data provide key information for the design of a Phase 3 study CELEBRATION, Fla., March 26, 2024 (GLOBE NEWSWIRE) --... ► Artikel lesen | |
| 26.03.24 | U.S. Energy Corp. Reports Financial and Operating Results for Full Year and Fourth Quarter 2023 | 628 | GlobeNewswire (Europe) | HOUSTON, March 26, 2024 (GLOBE NEWSWIRE) -- U.S. Energy Corporation (NASDAQ: USEG, "U.S. Energy" or the "Company"), a growth-focused energy company engaged in operating a portfolio of high-quality... ► Artikel lesen | |
| 26.03.24 | Actelis Networks, Inc.: Actelis Networks Reports Fiscal Full Year 2023 Results | 680 | GlobeNewswire (Europe) | FREMONT, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ: ASNS) ("Actelis" or the "Company"), a market leader in cyber-hardened, hybrid-fiber rapid deployment networking... ► Artikel lesen | |
| 26.03.24 | Logan Ridge Finance Corporation Announces Fourth Quarter and Full Year 2023 Financial Results | 504 | GlobeNewswire (Europe) | Reports Strong 2023 Results with Net Investment Income of $1.43 Per Share, Compared to a Net Investment Loss of $0.43 Per Share for Year Ended 2022; Total Investment Income Increased to $20.2 Million... ► Artikel lesen | |
| 26.03.24 | Progress Software Corporation: Progress Announces First Quarter 2024 Financial Results | 230 | GlobeNewswire (Europe) | First Quarter Revenues and Earnings Per Share Ahead of Estimates BURLINGTON, Mass., March 26, 2024 (GLOBE NEWSWIRE) -- Progress (Nasdaq: PRGS), the trusted provider of infrastructure software, today... ► Artikel lesen |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 3.914 |
| TESLA | 3.101 |
| STEYR MOTORS | 2.789 |
| DEUTZ | 2.702 |
| RENK GROUP | 2.681 |
| THYSSENKRUPP | 2.611 |
| TUI | 2.280 |
| NEL | 2.180 |
| BYD | 2.132 |
| RHEINMETALL | 2.118 |
| BAYER | 1.517 |
| XIAOMI | 1.458 |
| NOVO NORDISK | 1.374 |
| EVOTEC | 1.305 |
| COMMERZBANK | 1.170 |
| DEUTSCHE BANK | 1.150 |
| BASF | 1.028 |
| VOLKSWAGEN | 1.000 |
| MERCEDES-BENZ | 976 |
| AIXTRON SE | 971 |
| MUTARES | 960 |
| PUMA | 939 |
| PORSCHE AG | 916 |
| SUPER MICRO COMPUTER | 848 |
| HENSOLDT | 836 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
